Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
04/2012
04/17/2012US8158575 Agent for the prevention and treatment of sexually transmitted diseases-I
04/17/2012US8158574 Compositions and methods to prevent cancer with cupredoxins
04/17/2012US8158418 Chimeric alphavirus replicon particles
04/17/2012US8158416 CDNA corresponding to the antigenome of nonsegmented negative strand RNA viruses, and process for the production of such viruses encoding additional antigenically active proteins
04/17/2012US8158415 Combined use of cell permeable Nanog and Oct4 for increasing self-renewal and suppressing differentiation of stem cells
04/17/2012US8158385 Cell death-inducing agent
04/17/2012US8158383 Methods of generating protein variants
04/17/2012US8158372 Agonists of a bitter taste receptor and uses thereof
04/17/2012US8158369 Cancer diagnostic kit and cancer diagnostic method
04/17/2012US8158132 used to control the interaction of particular cell types with their external environment; for chronic pain; reduced side effects, long-lasting actions that do not require frequent injections or long-term catheterization; does not lead to tolerance and associated dependence
04/17/2012US8158131 Recombinant dengue virus antigens comprising the C15 signal peptide, full-length PRM protein, and full-length E protein
04/17/2012US8158130 Method for the preparation of virus-like particles (VLPS) comprising heterologous multiple membrane spanning proteins
04/17/2012US8158129 Dimeric alpha interferon PEGylated site-specifically shows enhanced and prolonged efficacy in vivo
04/17/2012US8158128 Monoclonal antibodies to progastrin
04/17/2012US8158123 Suppressing bone resorption; inhibiting expression of osteoclast associated gene selected from OC 1-285, sequences 4, 34, 38 and/or 43
04/17/2012CA2695562C Lipid acyltransferase
04/17/2012CA2499008C Compositions and methods comprising a ligand of chemerinr
04/17/2012CA2498636C Use of saccharomyces cerevisiae erg4 mutants for the expression of glucose transporters from mammals
04/17/2012CA2497982C Peptides and related molecules that modulate nerve growth factor activity
04/17/2012CA2491680C Inhibitors of ftsz and uses thereof
04/17/2012CA2481521C Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva)
04/17/2012CA2445700C Protein involved in restoration of cytoplasmic male sterility to fertility and gene encoding the protein and gene
04/17/2012CA2431600C Molecules with extended half-lives, compositions and uses thereof
04/17/2012CA2410526C Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds
04/17/2012CA2408328C Immunogenic polypeptides encoded by mage minigenes and uses thereof
04/17/2012CA2378871C Design of beta-sheet proteins with specific binding properties
04/17/2012CA2377607C Neurotrophic factor receptor
04/17/2012CA2372181C Adjuvant combination formulations
04/17/2012CA2363958C Low molecular weight peptide derivatives as inhibitors of the laminin/nidogen interaction
04/17/2012CA2347928C Cell surface molecule-induced macrophage activation
04/17/2012CA2225378C Cytokine that induces apoptosis
04/17/2012CA2202090C Papilloma virus-like particles, fusion proteins as well as processes for their production
04/17/2012CA2145778C Therapeutic and diagnostic methods and compositions based on notch proteins and nucleic acids
04/14/2012CA2817579A1 Gb1 peptidic libraries and compounds, and methods of screening the same
04/12/2012WO2012048291A2 Compositions and methods for inhibition of mmp:mmp-substrate interactions
04/12/2012WO2012048246A1 Reduction of antibody response against botulinum neurotoxin and variants thereof
04/12/2012WO2012048171A2 Variant cbh i polypeptides with reduced product inhibition
04/12/2012WO2012048115A2 Polypeptides and their use in treating and limiting respiratory syncytial virus infection
04/12/2012WO2012048063A2 Cyanine compounds, conjugates and method of use
04/12/2012WO2012047968A2 Mutant smoothened and methods of using the same
04/12/2012WO2012047930A2 Compositions and methods for treatment of gynecologic cancers
04/12/2012WO2012047584A2 Macaca fascicularis ccl17
04/12/2012WO2012047355A2 Subunit-selective nucleic acid inhibitors of glutamate receptors
04/12/2012WO2012047267A2 Polyvalent immunogen
04/12/2012WO2012047175A1 Fusion polypeptides comprising tir and dimerization domain for modulation of tlr/innate immunity signaling
04/12/2012WO2012046940A1 Composition for natural killer cell differentiation containing a tox as an active ingredient
04/12/2012WO2012046845A1 Peptide derivative and use thereof
04/12/2012WO2012046730A1 Method for activating helper t cell
04/12/2012WO2012046238A2 Erythropoietin receptor antagonists
04/12/2012WO2012046061A2 Clostridium difficile antigens
04/12/2012WO2012046006A2 Cancer targets
04/12/2012WO2012045733A1 Reversibly photoswitchable polypeptides
04/12/2012WO2012045334A1 Biologically active il-10 fusion proteins
04/12/2012WO2012023113A3 Designer osteogenic proteins
04/12/2012WO2012022894A4 Novel peptides which have analgesic effects and which inhibit asic channels
04/12/2012WO2012021076A3 A method of extracting lectin from the common bean as well as a lectin preparation
04/12/2012WO2012011144A3 Use of amino acid sequences from mycobacterium tuberculosis or corresponding nucleic acids for diagnosis and prevention of tubercular infection, diagnostic kit and vaccine therefrom
04/12/2012WO2012006540A3 Improving the efficiency of prion conversion in vitro and sensitivity of prion detection
04/12/2012WO2012003479A3 Methods for culturing undifferentiated cells using sustained release compositions
04/12/2012WO2011162805A3 Prion inactivation using ozone
04/12/2012WO2011157713A4 Cell-penetrating peptides and uses therof
04/12/2012WO2011156820A9 Compositions, methods and uses for treatment of type 1 diabetes
04/12/2012WO2011154403A3 Isolation of mesenchymal stem cells
04/12/2012WO2011126882A9 Therapeutic peptides and their derivatives and therapeutic uses thereof
04/12/2012WO2004076638A8 Polynucleotides and polypeptides in plants
04/12/2012US20120090052 Plants Having Enhanced Yield-Related Traits And A Method For Making The Same
04/12/2012US20120090043 Targets for retrovirus associated diseases
04/12/2012US20120089084 Wound healing device
04/12/2012US20120089076 Method for treating inflammation
04/12/2012US20120088904 Analysis of hcv genotypes
04/12/2012US20120088902 Methods and compositions for the treatment of gastrointestinal disorders
04/12/2012US20120088729 Non-glycosylated transferrin expressed in monocots
04/12/2012US20120088722 Compositions and methods for inhibition of mmp:mmp-substrate interactions
04/12/2012US20120088718 Hcv-derived polypeptides and uses thereof
04/12/2012US20120088717 Method for treating fungal infection with antifungal bifunctional molecules
04/12/2012US20120088716 Polypeptide Protracting Tags
04/12/2012US20120088715 Mutated antithrombins, a process for preparing the same and their use as drugs
04/12/2012US20120088312 Vincristine immunoassay
04/12/2012US20120088301 Factor taking part in transcription control
04/12/2012US20120088297 Mycobacterial antigens expressed under low oxygen tension
04/12/2012US20120088289 Vmp-like sequences of pathogenic borrelia species and strains
04/12/2012US20120088287 Cripto antagonism of activin and tgf-b signaling
04/12/2012US20120088272 Methods of generating hybrid/chimeric cells, and uses thereof
04/12/2012US20120088270 Methods for producing antifungal bifunctional molecules for treating fungal infection
04/12/2012US20120088262 Cyanine compounds, conjugates and method of use
04/12/2012US20120088256 Anaplasma translocated substrate-1 (ATS-1) and sero-detection of anaplasma phagocytophilum
04/12/2012US20120088255 Her-2 binding antagonists
04/12/2012US20120087969 Mu-Conotoxin Peptides and Use Thereof as a Local Anesthetic
04/12/2012US20120087938 Consensus/ancestral immunogens
04/12/2012US20120087936 Therapeutic and prophylactic vaccine for the treatment and prevention of papillomavirus infection
04/12/2012US20120087935 Serine rich peptides having antioxidative stress properties
04/12/2012US20120087932 Diagnostic test for virus
04/12/2012US20120087930 Marker of Streptococcus Anginosus/ Streptococcus Constellatus (MOAC) and Uses Thereof
04/12/2012US20120087918 Methods and compositions for inhibiting the growth of hematopoietic malignant cells
04/12/2012US20120087911 Crystal structure
04/12/2012US20120087910 Sparc angiogenic domain and methods of use
04/12/2012US20120087870 Novel caviidae allergens and uses thereof
04/12/2012US20120087863 Peptide Derivative and Use of the Same
04/12/2012DE10237517B4 Verfahren zur An- bzw. Abreicherung von Biomolekülen aus flüssigen oder fluiden Medien unter Verwendung von Schichtdoppelhydroxiden und Verwendung von an einem Schichtdoppelhydroxid an- oder eingelagerten Biomolekülen als anorganischer Vektor A method for enrichment or depletion of biomolecules from liquid or fluid media using Schichtdoppelhydroxiden and use of other on a layered double or embedded biomolecules as inorganic Vector
04/12/2012DE102010042356A1 Behälter für die Herstellung einer konditionierten Blutzusammensetzung Container for the production of a conditioned blood composition
1 ... 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 ... 2916